Type 2 diabetes (T2DM) Breast cancer/borstkanker Colorectal cancer/colorectale kanker Hypertension/hypertensie Dyslipidemia/dyslipidemie
Conditions
Interventions
None listed
Sponsors
Diabetes Kenniscentrum Zwolle
Eligibility
Inclusion criteria
Inclusion criteria: Patients with type 2 diabetes treated in primary care, who are diagnosed with primary breast- or colorectal cancer, between 1999 and 2012 and who are treated with curative intent. Curative intent for breast cancer was defined as stage 1 to 3 breast cancer or ductal carcinoma in situ (DCIS) of the breast. Curative intent for colorectal cancer was defined as stage 1 to 3, who received at least surgical treatment.
Exclusion criteria
Exclusion criteria: Patients with evidence of relapse, patients with other cancers than breast or colorectal cancer, or patients with a history of other cancers prior to breast or colorectal cancer with the exception for non-melanoma skin cancer and patients who received no cancer treatment or only hormone treatment in breast cancer are excluded. Patients without at least 1 year of follow-up in the ZODIAC study prior to the diagnosis of breast or colorectal cancer are also excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The proportion of patients who achieve their individual treatment goal at 0, 12 months and 24 months after cancer diagnosis and treatment compared to baseline. | — |
Secondary
| Measure | Time frame |
|---|---|
| The proportion of patients who achieve a target cholesterol/HDL ratio equal or below 4 at 0, 12 and 24 months compared to baseline. The proportion of patients who achieve a target systolic blood pressure equal to or below of 140 mmHg at 0, 12 and 24 months compared to baseline. | — |
Contacts
Public ContactDennis Schrijnders
Dr. Spanjaardweg 11, 2e etage
Outcome results
None listed